Tag Archives: Disease

FDA Approves New Treatments Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) for Heart Disease Caused by Transthyretin Mediated Amyloidosis

Print this page May 06, 2019 — On May 3, the U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for the treatment of the heart disease (cardiomyopathy) caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM. Vyndaqel and Vyndamax have the same active… Read More »

Disease has cost Africa 630 million years of ‘healthy life’, according to WHO study

A Ugandan doctor checks a Somali child at an outpatient hospital run by the African Union Mission in Somalia (AMISOM) in Mogadishu, Somalia. (Photo by John Moore/Getty Images) Diseases, disability and early death, resulting from illness, has cost the economy of the African continent’s 54 nations $ 2.4 trillion in annual workforce productivity losses in… Read More »